Special Issue on the Therapeutic Drug Monitoring of Anti-infective Drugs: Editorial

Affiliations

¹ Department of Clinical Microbiology and Infectious Diseases, St Vincent's Hospital, Sydney, Australia; and.
² Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.

Editorial

Deborah J E Marriott et al. Ther Drug Monit. 2022.

. 2022 Feb 1;44(1):1-2.

doi: 10.1097/FTD.0000000000000951.

¹ Department of Clinical Microbiology and Infectious Diseases, St Vincent's Hospital, Sydney, Australia; and.
² Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.

No abstract available

Conflict of interest statement

The authors declare no conflict of interest.

1. Koch B, Muller A, Hunfeld N, et al. Therapeutic drug monitoring of antibiotics in critically ill patients: current practice and future perspective with a focus on clinical outcome. Ther Drug Monit. 2022;44:11–18.
1. Ewoldt T, Abdulla A, Hunfeld N, et al. Health care costs of target attainment of beta-lactam antibiotics in critically ill patients: a retrospective analysis of the EXPAT study. Ther Drug Monit. 2022;44:224–229.
1. Abdulla A, Broek P, Ewoldt T, et al. Barriers and facilitators for the clinical implementation of beta-lactam therapeutic drug monitoring in critically ill patients: a critical review. Ther Drug Monit. 2022;44:103–111.
1. Stojanova J, Arancibia M, Ghimire S, et al. Understanding the pharmacokinetics of antibiotics in pregnancy: is there a role for therapeutic drug monitoring? A narrative review. Ther Drug Monit. 2022;44:50–64.
1. Touw D, van den Anker J. Therapeutic drug monitoring of antimicrobial drugs in neonates: an opinion article. Ther Drug Monit. 2022;44:65–74.